SU295559A1 - - Google Patents
Info
- Publication number
- SU295559A1 SU295559A1 SU942347A SU942347A SU295559A1 SU 295559 A1 SU295559 A1 SU 295559A1 SU 942347 A SU942347 A SU 942347A SU 942347 A SU942347 A SU 942347A SU 295559 A1 SU295559 A1 SU 295559A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- solution
- insulin
- water
- suspension
- crystalline
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000725 suspension Substances 0.000 description 5
- JIAARYAFYJHUJI-UHFFFAOYSA-L Zinc chloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- 239000011592 zinc chloride Substances 0.000 description 4
- 235000005074 zinc chloride Nutrition 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000005712 crystallization Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003513 alkali Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Publications (1)
Publication Number | Publication Date |
---|---|
SU295559A1 true SU295559A1 (fr) |
Family
ID=
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4529589A (en) * | 1981-07-14 | 1985-07-16 | Davydov Anatoly B | Pharmaceutical composition for the treatment of diabetes mellitus |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4529589A (en) * | 1981-07-14 | 1985-07-16 | Davydov Anatoly B | Pharmaceutical composition for the treatment of diabetes mellitus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112592312B (zh) | 一种托吡卡胺的制备方法 | |
CN100506210C (zh) | 一种头孢替唑钠粉针及其合成方法 | |
CN112552196B (zh) | 一种制备赖氨匹林的方法 | |
CN111138457A (zh) | 一种盐酸四咪唑的合成方法 | |
SU295559A1 (fr) | ||
CN112552167B (zh) | 葡萄糖酸钙的制备方法 | |
Jackson et al. | Crystalline β-Methyl-D-ribopyranoside1 | |
CN112279817B (zh) | 一种高纯度盐酸普拉克索的制备方法 | |
US2756226A (en) | Acid-stable penicillins | |
CN112430633B (zh) | 一种利用流加培养液发酵生产精氨酸的工艺 | |
JP4712166B2 (ja) | 結晶タガトースの製造方法 | |
CN112279867B (zh) | 一种头孢哌酮钠的制备方法 | |
CN112079779B (zh) | 一种喷他佐辛的合成方法 | |
CN110974832B (zh) | 一种注射用头孢孟多酯钠的制备方法 | |
US2881162A (en) | Recovery process | |
US3705150A (en) | Process for the preparation of 21-deoxy - 21-n-(n'-methylpiperazinyl)-prednisolone and salts thereof | |
JPS604189B2 (ja) | 抗菌剤およびその製法 | |
CN107151261B (zh) | 一种地红霉素化合物的晶型及其结晶制备方法 | |
CN113620975A (zh) | 一种硫酸头孢匹罗的合成方法 | |
SU648080A3 (ru) | Способ получени 1-трет.-бутиламино3-(2,5-дихлорфенокси)-2пропанола, его соли, рацемата или оптического антипода | |
TWI701248B (zh) | 吡喃葡萄糖取代的吡唑化合物、其製備方法及應用 | |
US3888916A (en) | Amantadine salt of 16,16-dimethyl-pge' 2 | |
CN103804204B (zh) | 一种制备维达列汀关键中间体3‑氨基‑1‑金刚烷醇的方法 | |
CN117447285A (zh) | 一种β-内酰胺酶抑制剂中间体手性杂质的制备方法 | |
WENNER | Meso-α, β-diaminosuccinic acid |